These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16466594)

  • 1. Psychosocial effects of age-related macular degeneration.
    Berman K; Brodaty H
    Int Psychogeriatr; 2006 Sep; 18(3):415-28. PubMed ID: 16466594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The psychosocial impact of macular degeneration.
    Williams RA; Brody BL; Thomas RG; Kaplan RM; Brown SI
    Arch Ophthalmol; 1998 Apr; 116(4):514-20. PubMed ID: 9565052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissatisfaction with performance of valued activities predicts depression in age-related macular degeneration.
    Rovner BW; Casten RJ; Hegel MT; Hauck WW; Tasman WS
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):789-93. PubMed ID: 17199237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity loss and depression in age-related macular degeneration.
    Rovner BW; Casten RJ
    Am J Geriatr Psychiatry; 2002; 10(3):305-10. PubMed ID: 11994218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New insights into the underestimated impairment of quality of life in age-related macular degeneration - a review of the literature].
    Meyer-Ruesenberg B; Richard G
    Klin Monbl Augenheilkd; 2010 Aug; 227(8):646-52. PubMed ID: 20449793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related macular degeneration: self-management and reduction of depressive symptoms in a randomized, controlled study.
    Brody BL; Roch-Levecq AC; Kaplan RM; Moutier CY; Brown SI
    J Am Geriatr Soc; 2006 Oct; 54(10):1557-62. PubMed ID: 17038074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The macular degeneration and aging study: Design and research protocol of a randomized trial for a psychosocial intervention with macular degeneration patients.
    Sörensen S; White K; Mak W; Zanibbi K; Tang W; O'Hearn A; Hegel MT
    Contemp Clin Trials; 2015 May; 42():68-77. PubMed ID: 25812482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing depression in age-related macular degeneration.
    Rovner BW; Casten RJ; Hegel MT; Leiby BE; Tasman WS
    Arch Gen Psychiatry; 2007 Aug; 64(8):886-92. PubMed ID: 17679633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-management of age-related macular degeneration at the 6-month follow-up: a randomized controlled trial.
    Brody BL; Roch-Levecq AC; Thomas RG; Kaplan RM; Brown SI
    Arch Ophthalmol; 2005 Jan; 123(1):46-53. PubMed ID: 15642811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on depression and age-related macular degeneration.
    Casten RJ; Rovner BW
    Curr Opin Ophthalmol; 2013 May; 24(3):239-43. PubMed ID: 23429599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological and Psychosocial Interventions for Depression and Anxiety in Patients With Age-Related Macular Degeneration: A Systematic Review.
    Senra H; Macedo AF; Nunes N; Balaskas K; Aslam T; Costa E
    Am J Geriatr Psychiatry; 2019 Aug; 27(8):755-773. PubMed ID: 31005495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related macular degeneration and depression: a review of recent research.
    Casten RJ; Rovner BW; Tasman W
    Curr Opin Ophthalmol; 2004 Jun; 15(3):181-3. PubMed ID: 15118503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality of life in patients with age-related macular degeneration - medical and social problem].
    Muzyka-Woźniak M; Misiuk-Hojło M; Wesolowska A
    Klin Oczna; 2011; 113(4-6):161-4. PubMed ID: 21913448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Affectivity and alexithymia: two dimensions explicative of the relationship between anxiety and depressive symptoms].
    Bonnet A; Bréjard V; Pasquier A; Pedinielli JL
    Encephale; 2012 Jun; 38(3):187-93. PubMed ID: 22726406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity.
    Bandello F; Lafuma A; Berdeaux G
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):96-103. PubMed ID: 17197522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser prophylaxis for age-related macular degeneration.
    Hsu J; Maguire MG; Fine SL
    Can J Ophthalmol; 2005 Jun; 40(3):320-31. PubMed ID: 15947802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive symptoms and quality of life in people with age- related macular degeneration.
    Mathew RS; Delbaere K; Lord SR; Beaumont P; Vaegan ; Madigan MC
    Ophthalmic Physiol Opt; 2011 Jul; 31(4):375-80. PubMed ID: 21679317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental regulation with progressive vision loss: Use of control strategies and affective well-being.
    Schilling OK; Wahl HW; Boerner K; Horowitz A; Reinhardt JP; Cimarolli VR; Brennan-Ing M; Heckhausen J
    Dev Psychol; 2016 Apr; 52(4):679-94. PubMed ID: 26845507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressive symptoms and age-related macular degeneration in older people: the cardiovascular health study.
    Sun C; Tikellis G; Klein R; Steffens DC; Larsen EK; Wong TY
    Ophthalmic Epidemiol; 2007; 14(3):127-33. PubMed ID: 17613847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related macular degeneration in Onitsha, Nigeria.
    Nwosu SN
    Niger J Clin Pract; 2011; 14(3):327-31. PubMed ID: 22037079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.